The Pharmacia Mono S column for glycated haemoglobin (HbA\c) was compared with Mono S HR 5/5 and three other cation exchange columns to optimize analysis of HbA lc' This column allows a significant decrease in separation time, resulting in a sample throughput of 12 samples per hour.
The measurement of glycated haemoglobin (HbA 1c) has become accepted as a valuable index of diabetic control.' A widely used method for analysis of HhAj, is ion exchange chromatography using the Mono S HR 5/5 colurnn.? This is a very robust method, suitable for routine measurements of HbA lc in clinical laboratories, with very high reproducibility.
The separation conditions for the original method-were based on studies with titration curves to achieve a suitable pH for separation. The method separates HbA lc from all known minor endogenous components except carbamylated haemoglobin! and may therefore be suitable as a method to be used for comparison of other techniques. The original sample preparationwas time consuming and has since been simplified." This simplified sample preparation requires the blood sample to be diluted to the appropriate concentration with borate buffer. After incubation for 30 min at 37°C to eliminate the labile fraction of HbA 1c, the sample is Correspondence: Dr S Eckerbom. suitable for direct injection into the chromatographic system. It has also been shown that a smaller amount of sample can be applied to enhance column life. 5 We investigated the possibility of reducing the separation time, and tested ion exchange columns other than Mono S HR 5/5 to assess their suitability for separation and determination of HbA lc'
MATERIALS AND METHODS
All chemicals used were of analytical grade from E Merck (Darmstadt, Germany).
Columns
The columns tested were Mono S HR 5/5, 50 mm X 5 mm internal diameter (lD) and Mono S for HbA 1c, 22 mm X 5 mm ID, both with 10 /Lm particles (Pharmacia LKB Biotechnology, Uppsala, Sweden), Spherogel TSK SP-5PW, 75 mm X 7·5 mm ID, 10 /Lm particles (Beckman Instruments Inc., San Ramon, CA, USA). ProteinPak 8HR SP, 50 mm X 5 mm, 8/Lm particles (Waters Associates, Milford, MA, USA) and NeoBar, 30 mm x 5 mm ID, l5/Lm particles (Dynochrom, Knivsta, Sweden). optimized to get adequate separation of HbA le from other haemoglobins in the shortest possible time while maintaining good separation.
Comparison with Mono S HR 5/5
Samples from 29 patients with diabetes mellitus were analysed using the optimized gradient for each column and the analytical results were Integration Integration of the peak areas of the chromatograms using valley-to-valley and baseline methods was compared ( Fig. 1) .
Intra-and inter-laboratory imprecision
A HbA 1e control preparation (Lyphochek), at two levels of HbA\e, was analysed 10 times and the intra-assay coefficient of variation (CV) was calculated. This control preparation was also used for an inter laboratory comparison of five clinical chemistry laboratories in Sweden, all using ion exchange chromatography. 2
Stability
Initially, the test samples were analysed on each column using the optimized gradients. To test the stability of the columns, approximately 1000 patient samples were analysed on each column followed by reanalysis of the test samples. The chromatographic performance and the analytical results of the second batch of test samples were compared with the initial batch.
Buffers
Buffer A was 0·02 mollL malonic acid. Buffer B was identical to buffer A with O· 3 mollL lithium chloride added. Sodium azide (0' 2 giL) was added to the buffers to prevent bacterial growth and the pH was adjusted to 5· 70 with saturated lithium hydroxide. The buffers were degassed and filtered through a 0·45 /Lm pore-size filter before use.
Chromatographic system The HPLC-system consisted of LKB 2249 pump and LKB 2152 UV detector operated at 415 run (Pharmacia LKB Biotechnology, Uppsala, Sweden), with an autoinjector (Jasco 85l-AS; Jasco International Corporation, Tokyo, Japan) and an integrator (Shimadzu C-R5A; Shimadzu Corporation, Kyoto, Japan).
Samples
Thirty venous blood samples were collected from diabetic patients in EDTA (ethylenediaminetetraacetic acid) Vacutainer tubes (Becton Dickinson Vacutainer Systems, Franklin Lakes, NJ, USA). One blood sample was spiked with cord blood to verify the separation of fetal haemoglobin (HbF) from HbA 1e. The samples were divided into aliquots and stored at -70°C during the experiments. A lyophilized glycated haemoglobin preparation (Lyphochek, Lot No. 49000; Bio-Rad Laboratories, Hercules, CA, USA) was used for intraand inter-laboratory assay imprecision studies.
Sample preparation
To 50 /LLofmixed blood, 1·0 mLofborate buffer (0'1 mol/L, pH 5 '9) was added. After incubation for 30 min to enhance the elimination of the labile fraction of HbA 1e, the tubes were centrifuged and 5/LL (approx 30/Lg haemoglobin) were injected into the chromatographic system.
EXPERIMENTAL Gradients
The separations on the columns tested were compared by performing a separation with an identical linear gradient on all columns. The chosen flowrate was 2·5 mLlmin and the gradient was 0-100010 buffer B over 20 min. In another set of experiments, the gradient for each column was National quality assurance of HbA l e analysis Before 1991 Sweden did not include HbA l c in any national quality assurance program. Beginning with week 10 in 1991, different levels of HbA l c preparations (Lyphochek, Bio-Rad) were sent out weekly. At the end of 1991, two Lyphochek preparations (Lot 49000) were analysed by five reference laboratories, appointed by the Swedish External Quality Assurance in Laboratory Medicine (SEQLA). These two preparations were then sent to all participating laboratories with a 'recommended value', and a recommendation to use valley-to-valley integration.
RESULTS AND DISCUSSION
Comparison of separation with linear gradients 0 With an identical linear gradient for all columns, 0-1000,10 of buffer B in 20 min at a flowrate of 2·5 mL/min all haemoglobin derivatives were eluted between 8 and 14 min as shown in is preferred for routine analysis of HbA 1e , when integration needs to be very robust and stable. It is also clear that valley-to-valley integration gives lower values than baseline integration.
Intraand inter-laboratory imprecision
HbA l e was determined in control preparations (Lyphochek, lot numbers 49001 and 49 002; Bio-Rad). The analytical results from all columns showed intra-assay CVs of less than 10/0 ( Table 2) . When these control preparations were analysed by five clinical chemistry laboratories, appointed as reference laboratories for HbA 1e analysis by SEQLA, inter-laboratory CVs of2'2% and 3·0% were achieved at HbA 1e levels of 8· 3% and 4'3%, respectively. These laboratories all used the ion exchange chromatography method-with valley-to-valley integration, but with different modifications and HPLC equipment.
Stability
For the two Mono S columns the chromatographic separations were unchanged after analysis of 1000 samples. Retention times for all haemoglobin fractions were identical to the initial separations. Slightly poorer agreement with initial results was obtained for the other three columns when the 29 patient samples initially analysed were reanalysed (Table 3) . Comparison witb Mono S DR 5/5 Samples from 29 patients were analysed using the optimized gradient for each column and the analytical results were compared to Mono S HR 5/5. All columns showed good agreement with Mono S HR 5/5 ( Table 4 ). Table 1 illustrate that baseline integration is much more sensitive to experimental chromatographic parameters than valley-to-valley integration, and the latter procedure exchange chromatography. At the end of 1991 two Lyphochek preparations (49001, 49 (02) were sent to all participating laboratories with a recommended value established by the five reference laboratories mentioned earlier and a recommendation to use valley-to-valley integration. In 1993 the interlaboratory CV was less than 5%. levels of HbA 1c are achieved with the Diamat system, Fig. 4 . The higher HbA 1c level with the Bio-Rad system is probably because the Diamat system does not have the same chromatographic efficiency as the HPLC system with the Mono S column, and complete separation of HbA 1c is not achieved.
results. The results shown in
National quality assurance of MbA l e analysis Figure 5 illustrates the results from the Swedish quality control scheme. During the first weeks the results showed an inter-laboratory CV of 15-200/0. All participating laboratories were using different modifications of HPLC ion exchange chromatography, except the two laboratories showing the highest values for week 10, 1991. They were both using affinity chromatography on disposable columns and later converted to ion .
CONCLUSION
All the columns tested could be used for HbA l c analysis. However, in this test the Mono S columns showed better long term stability. No change in efficiency or retention times could be observed for these columns after injection of WOO patient samples. Only by employing the new short Mono S column for HbA l c was it possible to decrease the separation time significantly. The Mono S column for HbA l c has now been used for routine analysis of HbA l c in our laboratory for more than two years with good results, and an analytical capacity of 10-12 samples per hour. If steeper gradients are used to achieve even shorter analysis times, the gradients will have to be optimized to the HPLC system used. The majority of clinical chemistry laboratories in Swedish hospitals use ion exchange chromatography for analysis of HbA l c ' A national quality control programme, the SEQLA has, since 1991, sent unknown samples every week to laboratories analysing HbA l c ' The initial results showed an inter-laboratory CV of 15-20070, which is unacceptable 1 but is similar to Ann Clin Biochem 1994: 31 results from other external quality assurance programmes.s As a result, recommendations (including the use of valley-to-valley integration) were given to the approximately 30 participating laboratories in Sweden. The inter-laboratory CVs of the participating laboratories are now less than 5%. Our experience is that valley-tovalley integration significantly enhances the reproducibility of the method and seems to be the better alternative for routine analysis of HbA l c ' When comparing results of HbA 1c analysis between different laboratories using the same method it is important that integration parameters are considered.
